Inhalable gene therapy tested for cystic fibrosis treatment in the UK and Europe

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.

Long COVID affects 38% of emergency patients with persistent symptoms

Researchers found that post-COVID-19 condition (PCC) symptoms persist in a significant number of both SARS-CoV-2 positive and negative emergency department patients, highlighting the non-specific nature

October 2, 2024

Biohaven’s data delay degrades stock price

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! Today, we dig

April 16, 2024

International experts set framework for microbiota diagnostics

The gut microbiota might perhaps one day become a routine tool for the early diagnosis of many diseases and to guide treatment, but at present

December 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.